Prescription-Strength Acne Science, Now OTC: The Clinical Confidence Behind Differin® Epiduo®

Join us for a webinar on the launch of Differin® Epiduo®, the first dual-active acne treatment approved by the FDA for over-the-counter use. This session will explore what makes the brand meaningful in today’s acne landscape: a dermatologist-trusted adapalene 0.1% and benzoyl peroxide 2.5% combination, proven clinical performance, and the opportunity to give patients easier access to an efficacious treatment without a prescription. We will cover the science behind the formulation, the depth of clinical support behind the brand, and how its prescription heritage translates into a compelling new OTC option for acne care.